Putative association of transforming growth factor-α polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

Journal of Viral Hepatitis

Volumn 17, Issue 7, 2010, Pages 518-526

  Kim, Y J ^a   Kim, H Y ^a   Kim, J S ^a   Lee, J H ^a   Yoon, J H ^a   Kim, C Y ^a   Park, B L ^b   Cheong, H S ^b   Bae, J S ^c   Kim, S ^d   Shin, H D ^b,c   Lee, H S ^a  

^a Seoul National University   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Sogang University   (South Korea)

^d Soongsil University   (South Korea)

Author keywords

Hepatitis B virus infection; Hepatocellular carcinoma; Polymorphisms; TGFA

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASIAN; CHRONIC HEPATITIS; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNITY; INFLAMMATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS HEPATITIS; CARCINOMA, HEPATOCELLULAR; COMPLICATION; GENETICS; IMMUNOLOGY; KOREA; LIVER NEOPLASMS; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; KOREA; LIVER NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR ALPHA; TREATMENT OUTCOME;

EID: 77953596327     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01205.x     Document Type: Article

References (43)

1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007 45 (2) 507-539.
2. Merican I, Guan R, Amarapuka D et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000 15 (12) 1356-1361.
3. Lin TM, Chen CJ, Wu MM et al. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989 9 (3) 737-741.
4. Yu MW, Chang HC, Liaw YF et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000 92 (14) 1159-1164.
5. Coursaget P, Yvonnet B, Chotard J et al. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 1987 22 (1) 1-5.
6. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975 292 (15) 771-774.
7. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987 92 (6) 1844-1850.
8. Kim YJ, Lee HS, Yoon JH et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 2003 12 (19) 2541-2546.
9. Shin HD, Park BL, Kim LH et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 2003 12 (8) 901-906.
10. Thio CL, Mosbruger T, Astemborski J et al. Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. J Virol 2005 79 (14) 9192-9196.
11. Thio CL, Mosbruger TL, Kaslow RA et al. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J Virol 2004 78 (20) 11258-11262.
12. Thio CL, Goedert JJ, Mosbruger T et al. An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection. 2004 5 (4) 294-300.
13. Kim YJ, Yoon JH, Kim CY et al. IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma. Biochem Biophys Res Commun 2006 346 (1) 38-44.
14. Kim YJ, Lee HS, Im JP et al. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 2003 35 (3) 196-202.
15. Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990 4 (2) 176-187.
16. Fausto N. Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin Liver Dis 1999 19 (3) 243-252.
17. Lee LW, Raymond VW, Tsao MS, Lee DC, Earp HS, Grisham JW. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells. Cancer Res 1991 51 (19) 5238-5244.
18. Morimitsu Y, Kleiner DE, Jr., Conjeevaram HS, Hsia CC, Di Bisceglie AM, Tabor E. Expression of transforming growth factor alpha in the liver before and after interferon alfa therapy for chronic hepatitis B. Hepatology 1995 22 (4 Pt 1) 1021-1026.
19. Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, Lee DC. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 1993 13 (1) 320-330.
20. Lee GH, Merlino G, Fausto N. Development of liver tumors in transforming growth factor alpha transgenic mice. Cancer Res 1992 52 (19) 5162-5170.
21. Takagi H, Sharp R, Hammermeister C et al. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice. Cancer Res 1992 52 (19) 5171-5177.
22. Zhang J, Wang WL, Li Q, Qiao Q. Expression of transforming growth factor-alpha and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance. World J Gastroenterol 2004 10 (6) 830-833.
23. An P, Nelson GW, Wang L et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA 2002 99 (15) 10002-10007.
24. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987 117 (2) 331-341.
25. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001 68 (4) 978-989.
26. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004 74 (4) 765-769.
27. Chung YH, Kim JA, Song BC et al. Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma. Cancer 2000 89 (5) 977-982.
28. Jakubczak JL, Chisari FV, Merlino G. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis. Cancer Res 1997 57 (16) 3606-3611.
29. Kira S, Nakanishi T, Suemori S, Kitamoto M, Watanabe Y, Kajiyama G. Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma. Liver 1997 17 (4) 177-182.
30. Harada K, Shiota G, Kawasaki H. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma. Liver 1999 19 (4) 318-325.
31. Morimitsu Y, Hsia CC, Kojiro M, Tabor E. Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-alpha and its receptor in the different areas of tumor. Hum Pathol 1995 26 (10) 1126-1132.
32. Burr AW, Toole K, Mathew J, Hines JE, Chapman C, Burt AD. Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis. J Pathol 1996 179 (3) 276-282.
33. Steinmetz KL, Klaunig JE. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci. Toxicol Appl Pharmacol 1996 140 (1) 131-145.
34. Barozzi C, Ravaioli M, D'Errico A et al. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer 2002 94 (3) 647-657.
35. Vail ME, Pierce RH, Fausto N. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha. Cancer Res 2001 61 (2) 594-601.
36. Tanaka S, Takenaka K, Matsumata T, Mori R, Sugimachi K. Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers. Dig Dis Sci 1996 41 (1) 208-215.
37. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991 324 (14) 933-940.
38. Raymond VW, Lee DC, Grisham JW, Earp HS. Regulation of transforming growth factor alpha messenger RNA expression in a chemically transformed rat hepatic epithelial cell line by phorbol ester and hormones. Cancer Res 1989 49 (13) 3608-3612.
39. Ignotz RA, Kelly B, Davis RJ, Massague J. Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells. Proc Natl Acad Sci USA 1986 83 (17) 6307-6311.
40. Massague J. Transforming growth factor-alpha. A model for membrane-anchored growth factors. J Biol Chem 1990 265 (35) 21393-21396.
41. Vieira AR. Association between the transforming growth factor alpha gene and nonsyndromic oral clefts: a HuGE review. Am J Epidemiol 2006 163 (9) 790-810.
42. Matsumoto K, Wassarman KM, Wolffe AP. Nuclear history of a pre-mRNA determines the translational activity of cytoplasmic mRNA. EMBO J 1998 17 (7) 2107-2121.
43. Bourdon V, Harvey A, Lonsdale DM. Introns and their positions affect the translational activity of mRNA in plant cells. EMBO Rep 2001 2 (5) 394-398.